my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
DiagnoCure (TSX: CUR) is a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services that increase clinician and patient confidence in making critical treatment decisions. DiagnoCure Oncology Laboratories from West Chester, PA, offers the PrevistageT more
DiagnoCure Inc. announced that four prominent colorectal cancer key opinion leaders have agreed to serve on the Strategic Advisory Board of its wholly owned subsidiary, DiagnoCure Oncology Laboratories. The Strategic Advisory Board is composed of Dr. Edith Mitchell, MD, FACP, Clinical Professor of more
New clinical data from a study of 570 men published in the peer-reviewed Journal of Urology (179:15871592, 2008) supports the use of a PCA3-based test as a tool for diagnosing prostate cancer. The new study confirms that PCA3, DiagnoCure's highly specific prostate cancer marker, and the world's firs more
DiagnoCure announced that preliminary results from an on-going multi-center study presented last week by independent researchers in Europe indicate that a new Gen-Probe PCA3-based test for prostate cancer yielded greater diagnostic accuracy than the free prostate specific antigen (PSA) test on men w more
DiagnoCure Inc. (CUR) - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the DiagnoCure Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development more
DiagnoCure Inc. (DiagnoCure) is engaged in the development, production and commercialization of immunoassay and molecular tests for the detection and management of cancer. The company commercializes high-value cancer diagnostic tests and lab services that increase clinician and patient confidence in more
Miraculins Inc (Miraculins) is a research and development company engaged in the discovery and validation of cancer biomarkers, which enable the development of diagnostic tools and therapeutic products. The company focuses on biomarker discovery using its proprietary B.E.S.T Platform for the screeni more
Corporate Overview Value of Diagnostics Management Team Contact / Request Info Collaborations ISO Certification Corporate History Awards & Honors Community Relations Home Since its founding in 1983, Gen-Probe has been at the forefront of the molecular diagnostics industry. Major accomplishments in t more
Français Site Map Glossary Contact Us Home About DiagnoCure Mission and History Board of Directors Management Scientific Partners Intellectual Property Investors Overview Q&A Financial Information Press Releases Strategy Management Presentations Analysts Corporate Governance Investors Contact News a more
You are now leaving the Gen-Probe US site and entering our Global site which contains information on products which are non FDA-Approved and not available for purchase in the US. Do you wish to continue to this product-specific site? Home | Contact Us | Visit Global Site Home › News Press Releases F more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
